Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Valentina Boyko
Does the Lipid-Lowering Peroxisome Proliferator-Activated Receptors Ligand Bezafibrate Prevent Colon Cancer in Patients With Coronary Artery Disease?
Cardiovascular Diabetology
Internal Medicine
Cardiology
Endocrinology
Cardiovascular Medicine
Metabolism
Diabetes
Attenuation of Progression of Insulin Resistance in Patients With Coronary Artery Disease by Bezafibrate
Archives of Internal Medicine
Related publications
Peroxisome Proliferator-Activated Receptors Associated With Nonalcoholic Fatty Liver Disease
PPAR Research
Drug Discovery
Pharmacology
Peroxisome Proliferator-Activated Receptors (Ppars) in Health and Disease.
Biomedical papers of the Medical Faculty of the University Palacky, Olomouc, Czechoslovakia
Biochemistry
Medicine
Genetics
Molecular Biology
Drugs and the Peroxisome Proliferator Activated Receptors
Pleiotropic Actions of Peroxisome Proliferator-Activated Receptors in Lipid Metabolism and Atherosclerosis
Arteriosclerosis, Thrombosis, and Vascular Biology
Cardiovascular Medicine
Cardiology
Peroxisome Proliferator-Activated Receptors in HCV-Related Infection
PPAR Research
Drug Discovery
Pharmacology
Peroxisome Proliferator-Activated Receptor Alpha Gene Variants Influence Progression of Coronary Atherosclerosis and Risk of Coronary Artery Disease
Circulation
Cardiovascular Medicine
Physiology
Cardiology
Peroxisome Proliferator-Activated Receptors and Hepatitis C Virus
Therapeutic Advances in Gastroenterology
Gastroenterology
Peroxisome-Proliferator-Activated Receptors (PPARs) Are Potential Drug Targets for Cancer Therapy
Oncotarget
Oncology
Intensive Lipid Lowering With Atorvastatin in Patients With Stable Coronary Disease
Journal of Vascular Surgery
Surgery
Cardiovascular Medicine
Cardiology